Rezvan Amiri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rezvan Amiri has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
A. Kariminejad
2 shared publicationsH. Najmabadi
2 shared publicationsH. Vahidnezhad
2 shared publicationsJ. Uitto
2 shared publicationsM. Fadaee
2 shared publications- Mehrshid Faraji Zonooz
Kariminejad-Najmabadi Pathology & Genetics Center, Tehran, Iran
2 shared publications
Latest Publications
- Open Access
- 31 March 2023
- Published by Hindawi Limited in Case Reports in Dermatological Medicine
- Vol. 2023, 1-6
Metformin-Induced Generalized Bullous Fixed-Drug Eruption with a Positive Dechallenge-Rechallenge Test: A Case Report and Literature Review
Metformin is a commonly used medication in diabetic patients. It can cause different complications including cutaneous adverse reactions. Metformin-induced fixed-drug eruption (FDE) has been reported in limited cases. Due to the popularity of metformin, clinicians need to be aware of uncommon drug reactions for proper diagnosis and treatment. Herein, we report a 43-year-old man with generalized bullous lesions with a positive dechallenge-rechallenge test diagnosed as metformin-induced generalized bullous fixed-drug eruption. Metformin dosage was stopped and lesions were treated with topical clobetasol propionate and oral prednisolone and cyclosporine-A. After a 6-month follow-up, he was well without any relapsing episodes.
- 31 March 2023
- Published by Hindawi Limited in Case Reports in Dermatological Medicine
- Vol. 2023, 1-6
Open AccessMetformin-Induced Generalized Bullous Fixed-Drug Eruption with a Positive Dechallenge-Rechallenge Test: A Case Report and Literature Review
Metformin is a commonly used medication in diabetic patients. It can cause different complications including cutaneous adverse reactions. Metformin-induced fixed-drug eruption (FDE) has been reported in limited cases. Due to the popularity of metformin, clinicians need to be aware of uncommon drug reactions for proper diagnosis and treatment. Herein, we report a 43-year-old man with generalized bullous lesions with a positive dechallenge-rechallenge test diagnosed as metformin-induced generalized bullous fixed-drug eruption. Metformin dosage was stopped and lesions were treated with topical clobetasol propionate and oral prednisolone and cyclosporine-A. After a 6-month follow-up, he was well without any relapsing episodes.
- Open Access
- 25 February 2022
- Published by Brieflands in Journal of Skin and Stem Cell
- Vol. 9 (1)
Clinicopathological Evaluation of Seborrheic Keratosis Lesions in Patients Referred to Afzalipour Hospital, Kerman, Iran
Background: Seborrheic keratosis is a benign epidermal proliferation, which is highly common in sun-exposed areas. This study evaluated the clinicopathological characteristics of seborrheic keratosis lesions in patients referred to the Afzalipour Hospital, Kerman, Iran. Methods: This retrospective cross-sectional study investigated ninety-nine skin biopsies of seborrheic keratosis lesions. The patients’ demographic features and the clinical and pathological features of the lesions were recorded. Then the correlation between pathological subtypes and demographics and clinical features was evaluated. Independent t-test and chi-square tests were used to assess the correlation between quantitative and qualitative data, respectively. Results: A majority of the patients were female (56.6%) in the sixth decade of their lives (33.3%). The lesions were more frequent in sun-exposed areas (65.6%). The most common pathological subtypes were acanthotic (47.5%), hyperkeratotic (27.3%), and adenoid (14.1%), and horn cyst (75.8%) and squamous eddies (5.1%) were the most and the least prevalent pathological features, respectively. Moreover, no significant correlation was noticed between pathological subtypes with the patients’ age or sun-exposed areas (P = 0.257 & P = 0.05, respectively) Conclusions: The most common pathological subtype in this study was the acanthotic type. There was no correlation between pathological subtypes and the patients’ demographic features. The most common clinicopathological correlation was associated with the sun-protected lesions.
- 25 February 2022
- Published by Brieflands in Journal of Skin and Stem Cell
- Vol. 9 (1)
Open AccessClinicopathological Evaluation of Seborrheic Keratosis Lesions in Patients Referred to Afzalipour Hospital, Kerman, Iran
Background: Seborrheic keratosis is a benign epidermal proliferation, which is highly common in sun-exposed areas. This study evaluated the clinicopathological characteristics of seborrheic keratosis lesions in patients referred to the Afzalipour Hospital, Kerman, Iran. Methods: This retrospective cross-sectional study investigated ninety-nine skin biopsies of seborrheic keratosis lesions. The patients’ demographic features and the clinical and pathological features of the lesions were recorded. Then the correlation between pathological subtypes and demographics and clinical features was evaluated. Independent t-test and chi-square tests were used to assess the correlation between quantitative and qualitative data, respectively. Results: A majority of the patients were female (56.6%) in the sixth decade of their lives (33.3%). The lesions were more frequent in sun-exposed areas (65.6%). The most common pathological subtypes were acanthotic (47.5%), hyperkeratotic (27.3%), and adenoid (14.1%), and horn cyst (75.8%) and squamous eddies (5.1%) were the most and the least prevalent pathological features, respectively. Moreover, no significant correlation was noticed between pathological subtypes with the patients’ age or sun-exposed areas (P = 0.257 & P = 0.05, respectively) Conclusions: The most common pathological subtype in this study was the acanthotic type. There was no correlation between pathological subtypes and the patients’ demographic features. The most common clinicopathological correlation was associated with the sun-protected lesions.
- 6 February 2022
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 21 (5) , 1874-1894
Carboxytherapy in dermatology: A systematic review
Introduction: The overall effects of Carboxytherapy, defined as the administration of carbon dioxide, have been studied for many years. It has been suggested that by improving oxygenation, interacting with the tissue perfusion regulators, and disrupting the adipose cell membranes, the method can lead to notable improvements in different esthetic and pathological conditions. Therefore, we aimed to systematically review the available studies evaluating the potential benefits of carboxytherapy in dermatological conditions and how it objectively stands against scientific scrutiny.Methods: We searched the PubMed, Scopus, Embase, and Web of Science databases, including the studies exploring the method's efficacy in managing any dermatological condition.Results: A total 27 of studies were identified (with a pooled sample of over 700 cases), most of which were clinical trials. Facial wrinkles, periorbital hyperpigmentation, skin laxity deficiency, scars, striae distensae, localized lipolysis and cellulite, alopecia, chronic diabetic wounds, and psoriatic plaques comprised the package of the dermatological conditions that were studied. Except for a few studies, the method mainly demonstrated significant improvements on all of the mentioned conditions. The inter‐ and post‐operational adverse events were mild and transient, including erythema, pain, crepitus, and ecchymoses.Discussion: Carboxytherapy can provide those practicing in the field with sustainably favorable results. However, the numbers of cases on whom the fat‐reducing capabilities of the method were studied and experienced varying degrees of recurrence caught our eye. In addition, we observed a notable disparity between the outcome measures utilized in the studies. The modest sample size in each condition also added to the injury, as the conditions on which the method was evaluated are pretty common in the general population. Therefore, for a definite conclusion, more randomized controlled trials with the shortcomings mentioned well addressed need to be conducted.
- 6 February 2022
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 21 (5) , 1874-1894
Carboxytherapy in dermatology: A systematic review
Introduction: The overall effects of Carboxytherapy, defined as the administration of carbon dioxide, have been studied for many years. It has been suggested that by improving oxygenation, interacting with the tissue perfusion regulators, and disrupting the adipose cell membranes, the method can lead to notable improvements in different esthetic and pathological conditions. Therefore, we aimed to systematically review the available studies evaluating the potential benefits of carboxytherapy in dermatological conditions and how it objectively stands against scientific scrutiny.Methods: We searched the PubMed, Scopus, Embase, and Web of Science databases, including the studies exploring the method's efficacy in managing any dermatological condition.Results: A total 27 of studies were identified (with a pooled sample of over 700 cases), most of which were clinical trials. Facial wrinkles, periorbital hyperpigmentation, skin laxity deficiency, scars, striae distensae, localized lipolysis and cellulite, alopecia, chronic diabetic wounds, and psoriatic plaques comprised the package of the dermatological conditions that were studied. Except for a few studies, the method mainly demonstrated significant improvements on all of the mentioned conditions. The inter‐ and post‐operational adverse events were mild and transient, including erythema, pain, crepitus, and ecchymoses.Discussion: Carboxytherapy can provide those practicing in the field with sustainably favorable results. However, the numbers of cases on whom the fat‐reducing capabilities of the method were studied and experienced varying degrees of recurrence caught our eye. In addition, we observed a notable disparity between the outcome measures utilized in the studies. The modest sample size in each condition also added to the injury, as the conditions on which the method was evaluated are pretty common in the general population. Therefore, for a definite conclusion, more randomized controlled trials with the shortcomings mentioned well addressed need to be conducted.
- 1 September 2016
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 136 (9) , S188
159 PASH syndrome is not a genetically distinct entity but belongs to the spectrum of autoinflammatory skin phenotypes
- 1 September 2016
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 136 (9) , S188
159 PASH syndrome is not a genetically distinct entity but belongs to the spectrum of autoinflammatory skin phenotypes
- Open Access
- 1 May 2016
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 136 (5) , S68
384 Whole genome linkage analysis followed by whole exome sequencing identifies nicastrin ( NCSTN ) as a causative gene in a multiplex family with γ-secretase associated autoinflammatory skin phenotypes
- 1 May 2016
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 136 (5) , S68
Open Access384 Whole genome linkage analysis followed by whole exome sequencing identifies nicastrin ( NCSTN ) as a causative gene in a multiplex family with γ-secretase associated autoinflammatory skin phenotypes